Jump to content


Mass production of Thailand’s ChulaCov 19 mRNA vaccine expected early next year


webfact

Recommended Posts

FBC660EF-C8A5-44FC-9B8D-BA52DC653FF6.jpg

 

Thailand’s Chulalongkorn University is expected to transfer technology for the mass production of its vaccine, ChulaCov 19 mRNA, to a local manufacturer in the first quarter of next year, according to Professor Dr. Kiat Ruxrungtham, director of the vaccine’s development project.

 

Speaking at a panel discussion on the progress of research and development of the vaccine, at the 5th Chula The Impact event on Thursday, Dr. Kiat said that the centre started the first stage of human clinical trials of the candidate vaccine on June 14th, involving 36 volunteers in the 18-55 age group and 36 volunteers aged 56-75. The two groups of volunteers were given two doses of vaccine three weeks apart.

 

Initial trial results show no serious side effects in the volunteers of the 18-55 age group, with mild and moderate side effects which improve in 1-2 days, said Dr. Kiat, adding that consultations are under way with the Thai Food and Drug Administration (TFDA) for the launch of the second phase of human clinical trials.

 

Discover Cigna’s range of health insurance solutions created for expats and local nationals living in Thailand - click to view

 

Full story: https://www.thaipbsworld.com/mass-production-of-thailands-chulacov-19-mrna-vaccine-expected-early-next-year/

 

Logo-top-.png
Link to comment
Share on other sites

24 minutes ago, webfact said:

Thailand’s Chulalongkorn University is expected to transfer technology for the mass production of its vaccine, ChulaCov 19 mRNA, to a local manufacturer in the first quarter of next year

Should they not complete clinical trials and possibly peer reviews prior to issuing these kind of statements .....????????

  • Like 1
Link to comment
Share on other sites

21 minutes ago, Geoffggi said:

Should they not complete clinical trials and possibly peer reviews prior to issuing these kind of statements .....????????

No this is Thailand they do what they want as evidenced by using the Fa Talai Jones and Favipiravir.

  • Like 1
Link to comment
Share on other sites

6 hours ago, webfact said:

Thailand’s Chulalongkorn University is expected to transfer technology for the mass production of its vaccine, ChulaCov 19 mRNA, to a local manufacturer in the first quarter of next year,

Maybe in time for boosters.

  • Like 1
Link to comment
Share on other sites

I can’t see this getting WHO approval based on the extent of the trials referenced in the article. And no WHO approval means not accepted by other countries. So presumably this is for those who have no intention to travel and are sufficiently uneducated to take a vaccine on trust rather than scientific evidence.

 

personally I’ll give it pass, but my wife is turning down every other vaccine while she waits for this one. Based on……nationalistic fervor?

  • Like 2
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.